1. Search Result
Search Result
Targets Recommended: NEDD8-activating Enzyme
Results for "


" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-P99107
    Brentuximab vedotin

    Antibody-Drug Conjugates (ADCs) Apoptosis Cancer
    Brentuximab vedotin (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) comprising an anti- CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE). Brentuximab vedotin inhibits CD30-positive cells with an IC50 of 2.5 ng/mL. Brentuximab vedotin can be used for the research of relapsed and refractory Hodgkin lymphoma.